Winner Medical Co., Ltd.
SZSE:300888.SZ
38.48 (CNY) • At close October 26, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | 2019 Q3 | 2019 Q2 | 2019 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 2,036.538 | 2,104.145 | 1,892.704 | 2,158.177 | 1,743.604 | 1,914.723 | 2,352.115 | 3,709.014 | 2,484.373 | 2,835.607 | 2,322.337 | 2,217.48 | 1,760.075 | 1,791.321 | 2,268.545 | 3,010.797 | 5,343.37 | 2,696.804 | 1,482.975 | 1,455.96 | 1,013.224 | 1,052.721 | 1,052.721 |
| Cost of Revenue
| 1,079.451 | 1,175.398 | 999.874 | 1,297.081 | 923.527 | 918.086 | 1,153.343 | 2,355.977 | 1,343.329 | 1,427.683 | 1,212.874 | 1,062.729 | 1,043.727 | 893.74 | 1,028.049 | 1,518.043 | 1,784.65 | 1,110.261 | 657.468 | 754.429 | 410.174 | 528.99 | 528.99 |
| Gross Profit
| 957.087 | 928.746 | 892.83 | 861.096 | 820.077 | 996.638 | 1,198.772 | 1,353.037 | 1,141.044 | 1,407.924 | 1,109.463 | 1,154.751 | 716.347 | 897.58 | 1,240.496 | 1,492.754 | 3,558.72 | 1,586.542 | 825.508 | 701.532 | 603.05 | 523.73 | 523.73 |
| Gross Profit Ratio
| 0.47 | 0.441 | 0.472 | 0.399 | 0.47 | 0.521 | 0.51 | 0.365 | 0.459 | 0.497 | 0.478 | 0.521 | 0.407 | 0.501 | 0.547 | 0.496 | 0.666 | 0.588 | 0.557 | 0.482 | 0.595 | 0.498 | 0.498 |
| Reseach & Development Expenses
| 88.538 | 61.947 | 76 | 48.811 | 74.26 | 83.457 | 111.179 | 113.146 | 135.793 | 144.234 | 94.411 | 26.538 | 81.707 | 90.727 | 99.19 | 69.4 | 173.138 | 124.93 | 43.915 | 43.265 | 51.934 | 29.997 | 29.997 |
| General & Administrative Expenses
| 425.259 | -111.614 | 151.789 | -259.584 | 384.597 | -102.958 | 148.745 | 119.153 | 399.631 | -48.439 | 128.016 | -159.334 | 191.766 | -114.985 | 153.48 | -149.377 | 103.447 | -23.57 | 63.178 | -276.03 | 51.768 | 45.199 | 45.199 |
| Selling & Marketing Expenses
| 1,026.243 | 577.903 | 477.838 | 644.986 | 485.064 | 490.123 | 470.32 | 650.116 | 449.889 | 480.376 | 469.796 | 751.938 | 411.424 | 433.49 | 392.316 | 215.268 | 571.584 | 488.795 | 299.517 | 454.183 | 295.898 | 227.847 | 227.847 |
| SG&A
| 677.708 | 637.197 | 634.68 | 790.63 | 869.661 | 387.165 | 619.065 | 766.967 | 849.519 | 431.937 | 597.811 | 592.604 | 603.19 | 318.506 | 545.796 | 65.892 | 675.031 | 465.225 | 362.695 | 178.153 | 347.667 | 347.592 | 347.592 |
| Other Expenses
| -19.17 | -38.23 | -17.745 | -246.33 | -63.157 | 60.978 | -0.62 | -19.817 | -245.831 | 253.136 | 5.092 | 50.3 | -21.939 | 19.975 | -9.076 | -10.014 | -0.561 | -3.974 | -4.354 | 20.958 | 2.743 | 0 | 0 |
| Operating Expenses
| 747.076 | 737.374 | 728.425 | 1,085.772 | 689.808 | 705.717 | 729.624 | 860.296 | 739.481 | 829.306 | 697.314 | 1,015.817 | 416.162 | 618.019 | 654.759 | 460.798 | 879.458 | 711.939 | 417.596 | 554.365 | 405.441 | 384.823 | 384.823 |
| Operating Income
| 210.011 | 191.373 | 164.404 | -224.676 | 1,738.186 | 366.57 | 452.707 | 492.741 | 434.129 | 625.638 | 424.041 | 198.817 | 366.254 | 333.903 | 576.667 | 830.868 | 2,484.111 | 834.908 | 381.85 | 161.502 | 209.289 | 135.773 | 135.773 |
| Operating Income Ratio
| 0.103 | 0.091 | 0.087 | -0.104 | 0.997 | 0.191 | 0.192 | 0.133 | 0.175 | 0.221 | 0.183 | 0.09 | 0.208 | 0.186 | 0.254 | 0.276 | 0.465 | 0.31 | 0.257 | 0.111 | 0.207 | 0.129 | 0.129 |
| Total Other Income Expenses Net
| -0.807 | 10.168 | 59.356 | -1,582.28 | -3.517 | 1.338 | -0.482 | -44.125 | -6.438 | -2.79 | -3.69 | -1.839 | -4.877 | 2.912 | -9.076 | -21.575 | -0.561 | -3.974 | -4.354 | -6.871 | 2.256 | 0.386 | 0.386 |
| Income Before Tax
| 209.204 | 257.35 | 223.7 | -1,806.956 | 1,734.669 | 367.909 | 453.164 | 448.616 | 427.691 | 622.847 | 420.351 | 196.977 | 361.377 | 336.815 | 567.591 | 810.479 | 2,483.55 | 830.935 | 377.496 | 154.631 | 212.032 | 135.875 | 135.875 |
| Income Before Tax Ratio
| 0.103 | 0.122 | 0.118 | -0.837 | 0.995 | 0.192 | 0.193 | 0.121 | 0.172 | 0.22 | 0.181 | 0.089 | 0.205 | 0.188 | 0.25 | 0.269 | 0.465 | 0.308 | 0.255 | 0.106 | 0.209 | 0.129 | 0.129 |
| Income Tax Expense
| 29.24 | 36.903 | 30.248 | -248.509 | 254.923 | 49.663 | 65.224 | 41.08 | 58.418 | 82.886 | 62.784 | 63.578 | 18.451 | 56.501 | 86.785 | 151.003 | 355.157 | 116.296 | 57.454 | 12.739 | 37.092 | 20.692 | 20.692 |
| Net Income
| 168.817 | 201.726 | 182.425 | -1,567.37 | 1,466.156 | 304.679 | 376.938 | 400.424 | 357.469 | 535.722 | 357.101 | 135.279 | 343.003 | 280.456 | 480.583 | 660.314 | 2,117.88 | 713.412 | 318.806 | 141.729 | 174.633 | 114.966 | 114.966 |
| Net Income Ratio
| 0.083 | 0.096 | 0.096 | -0.726 | 0.841 | 0.159 | 0.16 | 0.108 | 0.144 | 0.189 | 0.154 | 0.061 | 0.195 | 0.157 | 0.212 | 0.219 | 0.396 | 0.265 | 0.215 | 0.097 | 0.172 | 0.109 | 0.109 |
| EPS
| 0.29 | 0.35 | 0.31 | -2.66 | 2.51 | 0.52 | 0.64 | 0.67 | 0.84 | 1.26 | 0.84 | 0.23 | 0.8 | 0.66 | 0.81 | 1.76 | 4.02 | 1.89 | 0.6 | 0.37 | 0.33 | 0.22 | 0.22 |
| EPS Diluted
| 0.29 | 0.35 | 0.31 | -2.66 | 2.51 | 0.52 | 0.64 | 0.67 | 0.84 | 1.26 | 0.84 | 0.23 | 0.8 | 0.66 | 0.81 | 1.76 | 4.02 | 1.89 | 0.6 | 0.37 | 0.33 | 0.22 | 0.22 |
| EBITDA
| 222.848 | 420.377 | 235.016 | -1,633.327 | 1,909.814 | 523.522 | 606.727 | 453.856 | 590.041 | 749.538 | 542.087 | 307.573 | 479.62 | 454.38 | 672.686 | 902.239 | 2,482.682 | 875.694 | 408.053 | 158.036 | 214.242 | 160.66 | 160.66 |
| EBITDA Ratio
| 0.109 | 0.162 | 0.128 | -0.031 | 0.082 | 0.225 | 0.219 | 0.122 | 0.165 | 0.248 | 0.19 | 0.134 | 0.19 | 0.199 | 0.263 | 0.3 | 0.486 | 0.325 | 0.275 | 0.12 | 0.205 | 0.153 | 0.153 |